| |
| |
|
| Insider
Information: |
Riggs Rory B |
| Relationship: |
Chief Executive Office... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
3,819,637 |
|
|
Indirect Shares
|
745,498 |
|
|
| Direct
Value |
$42,870,305 |
|
|
|
Indirect Value
|
$3,846,662 |
|
|
| Total
Shares |
4,565,135 |
|
|
| Total
Value |
$46,716,967 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
30
|
|
Stock
price went up :
|
1
|
12
|
| Stock
price went down : |
2
|
18
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -14.7%
|
-179.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrogen Inc |
FGEN |
Director |
2021-05-26 |
395,750 |
2021-05-26 |
605,713 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-02-20 |
320,099 |
2024-02-20 |
100,187 |
Premium* |
|
|
Cibus Inc |
CBUS |
Chief Executive Office... |
2023-12-29 |
3,103,788 |
2023-12-29 |
39,598 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FGEN |
Fibrogen Inc |
Director |
– • – |
2014-11-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
372,014 |
|
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2014-11-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
420,200 |
|
- |
|
| CBUS |
Cibus Inc |
Chief Executive Officer |
• • • |
2023-06-01 |
4 |
B |
$31.50 |
$31,500 |
D/D |
1,000 |
1,154,464 |
3.23 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-09-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,250 |
381,650 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
382,900 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
386,350 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
391,050 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
395,750 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,747 |
14,509 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-03-29 |
4 |
S |
$36.95 |
$366,766 |
D/D |
(9,926) |
1,586,786 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-13 |
4 |
S |
$53.07 |
$671,743 |
D/D |
(12,402) |
379,200 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-11-16 |
4 |
S |
$42.01 |
$527,805 |
D/D |
(12,565) |
684,833 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-06-18 |
4 |
B |
$28.00 |
$420,000 |
I/I |
15,000 |
15,000 |
2.1 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
16,274 |
631,386 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-12 |
4 |
S |
$54.98 |
$1,082,721 |
D/D |
(19,693) |
391,602 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-12-09 |
4 |
S |
$42.07 |
$840,939 |
D/D |
(19,990) |
136,722 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2016-12-16 |
4 |
S |
$20.87 |
$417,310 |
D/D |
(20,000) |
460,200 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-03-09 |
4 |
S |
$55.75 |
$1,276,954 |
D/D |
(22,905) |
411,295 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2015-09-11 |
4 |
S |
$27.56 |
$675,927 |
D/D |
(24,429) |
505,771 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-09-29 |
4 |
S |
$36.50 |
$899,706 |
D/D |
(24,648) |
615,112 |
0 |
% |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2017-09-13 |
4 |
S |
$51.92 |
$1,298,000 |
D/D |
(25,000) |
435,200 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2015-09-14 |
4 |
S |
$27.56 |
$704,737 |
D/D |
(25,571) |
480,200 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-05-19 |
4 |
S |
$40.09 |
$1,054,651 |
D/D |
(26,304) |
575,408 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-06-29 |
4 |
S |
$42.17 |
$1,265,238 |
D/D |
(30,000) |
421,712 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-01-04 |
4 |
S |
$27.55 |
$983,504 |
D/D |
(35,702) |
20,099 |
0 |
% |
|
73 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
